HOME FIRST (Home Followed-up by the Infection Respiratory Support Team)

ISRCTN ISRCTN25542492
DOI https://doi.org/10.1186/ISRCTN25542492
ClinicalTrials.gov number NCT02454114
Secondary identifying numbers V1
Submission date
21/08/2012
Registration date
16/10/2012
Last edited
13/03/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Lower respiratory tract infections (LRTIs) are infections that affect the airways and lungs. Many patients with LRTIs could be treated as outpatients rather than stay in hospital. HOME FIRST is a new scheme that will enable patients with LRTIs to be discharged from hospital early and receive care in their own home. This study will investigate patient uptake to such a scheme, and compare HOME FIRST to current standard hospital care with regards to factors such as safety, death rates, readmission rates, rate of recovery, and care satisfaction.

Who can participate?
Patients aged 18 or over with lower respiratory tract infections.

What does the study involve?
Participants are randomly allocated to either HOME FIRST or standard hospital care. They are followed up by telephone at 2 weeks and at an outpatient clinic at 1 and 6 months.

What are the possible benefits and risks of participating?
Not provided at time of registration.

Where is the study run from?
Liverpool School of Tropical Medicine (UK).

When is study starting and how long is it expected to run for?
December 2011 to May 2012.

Who is funding the study?
NIHR Biomedical Research Centres (BRC).

Who is the main contact?
Prof Stephen Gordon

Contact information

Prof Stephen Gordon
Scientific

Liverpool School of Tropical Medicine
Pembroke Place
Liverpool
L3 5QA
United Kingdom

Study information

Study designRandomised control feasibility study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleHOME FIRST (Home Followed-up by the Infection Respiratory Support Team): a feasibility study
Study acronymHOME FIRST
Study objectivesThat HOME FIRST (Home Followed-up with Infection Respiratory Support Team) is an early supported discharge scheme feasibility study where patients are randomised to HOME FIRST or standard hospital care is acceptable to patients.

More details can be found here: http://public.ukcrn.org.uk/Search/StudyDetail.aspx?StudyID=12493
Ethics approval(s)Liverpool NHS Research Ethics Committee, 12/10/2011, ref: 11/NW/0670
Health condition(s) or problem(s) studiedRespiratory infection, including lower respiratory tract infection, pneumonia and bronchiectasis
InterventionHOME FIRST - Early supported hospital discharge or standard hospital care
Intervention typeOther
Primary outcome measurePatient acceptability
Secondary outcome measures1. Safety/mortality
2. Readmission rate
3. Length of stay
4. Total days of care
5. Functional and symptom improvement
Overall study start date10/12/2011
Completion date05/05/2012

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsScreen 200 or recruit 200
Key inclusion criteriaPatients with any of the following conditions:
1. Pneumonia - community-acquired (CAP) or hospital-acquired (HAP) - pneumonia definition - a series of clinical symptoms with radiological consolidation
N.B. All pneumonia CURB-65 scores will be considered but patients with CURB-65 ≥3 MUST have had at least 24hrs of in-patient observation before recruitment into the study.
2. Acute tracheo-bronchitis & acute bronchitis
3. Non-pneumonic lower respiratory tract infection
4. Influenza with respiratory manifestations
5. Infective exacerbation of bronchiectasis
6. Lung abscess
7. Pneumonia with concomitant COPD (if this service is not provided elsewhere)

Patient Suitability:
1. Simple pleural effusions only (if no diagnostic pleural tap performed please discuss)
2. Can manage ADLs with current support (immediate OT/physio/social assessment/care can be arranged prior to discharge (if needed) and continued at home)
3. Able to give fully informed consent
4. Has a phone
5. Age>18yrs old
6. EWS ≤2 AND SBP>90 (all observations must be stable for 12-24hrs) AND mild confusion only (defined as an 10-point AMTS ≥7)
7. All observations must be stable for 12-24hrs
8. Improving inflammatory markers (WCC/CRP)
9. Stable or improving U&Es
Key exclusion criteria1. Acute exacerbations of COPD - infective & non-infective (other services already provided)
2. Patients with CURB-65 >3 admitted<24hrs ago
3. Patients unable to manage at home even with maximal support from HOME FIRST (this may include some patients IV drug users, with ETOH excess or mental health problems)
4. Serious co-morbidities requiring hospital treatment (eg: CKD, CCF) or deemed unstable (significant AKD)
5. Suspected MI/raised TnI/T consistent with NSTEMI (Or acute ECG changes) within 5 days of discharge
6. Empyema or complicated parapneumonic effusion
7. SBP<90mmHg
8. Neutropenia
9. No fixed abode
10. Tuberculosis suspected
11. Well enough for discharge without HOME FIRST homecare support
12. Sats <92% on air - for patients without chronic respiratory illness
13. Sats <88% on air [except asthma sats must be >92%] - for patients with chronic respiratory illness. All such cases MUST be discussed as oxygen assessment may be needed.
Date of first enrolment10/12/2011
Date of final enrolment05/05/2012

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Liverpool School of Tropical Medicine
Liverpool
L3 5QA
United Kingdom

Sponsor information

Royal Liverpool and Broadgreen University Hospitals NHS Trust (UK)
Hospital/treatment centre

c/o Heather Rogers
Prescot Street
Liverpool
L7 8XP
England
United Kingdom

Website http://www.rlbuht.nhs.uk/
ROR logo "ROR" https://ror.org/009sa0g06

Funders

Funder type

Government

NIHR Biomedical Research Centres (BRC) - PASS (Pneumonia Aetiology and severity)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 26/02/2014 Yes No

Editorial Notes

13/03/2020: Internal review.
22/05/2019: ClinicalTrials.gov number added.